These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20887344)
21. [On oral medications, especially varenicline]. Kurioka N Nihon Rinsho; 2013 Mar; 71(3):487-92. PubMed ID: 23631241 [TBL] [Abstract][Full Text] [Related]
22. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946 [TBL] [Abstract][Full Text] [Related]
23. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Tashkin DP; Rennard S; Taylor Hays J; Lawrence D; Marton JP; Lee TC Respir Med; 2011 Nov; 105(11):1682-90. PubMed ID: 21621992 [TBL] [Abstract][Full Text] [Related]
24. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367 [TBL] [Abstract][Full Text] [Related]
25. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. Faessel HM; Smith BJ; Gibbs MA; Gobey JS; Clark DJ; Burstein AH J Clin Pharmacol; 2006 Sep; 46(9):991-8. PubMed ID: 16920893 [TBL] [Abstract][Full Text] [Related]
26. [Varenicline--a new chance for smokers?]. Goniewicz ML; Koszowski B; Czogała J; Sobczak A Przegl Lek; 2007; 64(10):899-902. PubMed ID: 18409337 [TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. Knight C; Howard P; Baker CL; Marton JP Value Health; 2010; 13(2):209-14. PubMed ID: 19912599 [TBL] [Abstract][Full Text] [Related]
28. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116 [TBL] [Abstract][Full Text] [Related]
29. Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Gonzales D; Hajek P; Pliamm L; Nackaerts K; Tseng LJ; McRae TD; Treadow J Clin Pharmacol Ther; 2014 Sep; 96(3):390-6. PubMed ID: 24911368 [TBL] [Abstract][Full Text] [Related]
30. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand. Harrison-Woolrych M; Ashton J Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of varenicline for smoking cessation. Hays JT; Ebbert JO; Sood A Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165 [TBL] [Abstract][Full Text] [Related]
32. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects! Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119 [No Abstract] [Full Text] [Related]
33. Practical implementation of varenicline as an aid to smoking cessation in clinical practice. Tonstad S Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313 [TBL] [Abstract][Full Text] [Related]
34. Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders. Castle D; Baker AL; Richmond R; Filia SL; Harris D; Pirola-Merlo AJ Ann Clin Psychiatry; 2012 Nov; 24(4):285-91. PubMed ID: 23145385 [TBL] [Abstract][Full Text] [Related]
35. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Rigotti NA; Pipe AL; Benowitz NL; Arteaga C; Garza D; Tonstad S Circulation; 2010 Jan; 121(2):221-9. PubMed ID: 20048210 [TBL] [Abstract][Full Text] [Related]
37. Varenicline for smoking cessation. Harrison-Woolrych M BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037 [No Abstract] [Full Text] [Related]
38. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database. Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037 [TBL] [Abstract][Full Text] [Related]
39. A preliminary investigation of varenicline for heavy drinking smokers. Fucito LM; Toll BA; Wu R; Romano DM; Tek E; O'Malley SS Psychopharmacology (Berl); 2011 Jun; 215(4):655-63. PubMed ID: 21221531 [TBL] [Abstract][Full Text] [Related]